StockWatch
·
LTM · Q2 FY-27 · THE VERDICT

13.6% Revenue Growth, Flat Profit: The Earnings Leverage Gap

LTIMindtree's Q2 delivery—strong 13.6% YoY revenue growth, powered by 40% AI expansion—masks a troubling earnings gap: PAT barely budged, flat YoY, and sequential momentum (1.7% QoQ) came in modest. Management's vague guidance and FII/DII trimming suggest the market has already priced execution risk.

Q2 FY27 resultsLTMLTIMindtree Ltd22 Oct 2026 · 6 min read
Revenue

₹11,808 Cr

+13.6% YoY; +1.7% QoQ

Net Profit

₹1,380 Cr

-0.1% YoY; -6.0% QoQ

EBIT Margin

15.6%

+10 bps QoQ; flat YoY

PAT Margin

11.7%

-100 bps QoQ (vs 12.7% Q1)

On the surface, a 13.6% YoY revenue beat reads bullish. But dig into the profit line and a different story emerges. Net profit grew flat YoY—essentially unchanged from ₹1,380.4 Cr a year ago—despite ₹1,600+ Cr in incremental revenue. Worse, sequential PAT declined 6.0% QoQ while revenue edged up just 1.7%. This is the Q2 paradox: strong top-line growth, absent earnings leverage.

Why the Leverage Disappeared

Three factors combine to explain the earnings softness. First, Q1 benefited from a one-time Voicing.AI investment gain that inflated the PAT margin to 12.7%; Q2's 11.7% margin is a normalization, not a collapse. Second, Q2 absorbed multiple outflows that temporarily depressed cash flow: a multi-month gratuity provision funding (labour code liability), TDS advances (India and US), and dividend payment timing. Operating cash flow shrank to ₹331 Cr (a 24% conversion of ₹1,380 Cr PAT) from 63% in Q1. Third, and most concerning, revenue growth isn't translating into margin expansion; cost headwinds—wage inflation, gratuity liability, deal mix effects—are offsetting operating leverage. Management expects gratuity and TDS outflows to normalize by October, bringing cash flow conversion back toward historic levels in Q3, but the underlying earnings leverage gap remains.

Gratuity provisions taken in Q3 last year; now funding that obligation [through October]. TDS outflows both India/US happening this quarter. Dividend TDS paid in Q2, not Q1. All are one-offs. Expect normalization in Q3.

Management's Claims: What Held Up

Claim versus delivered reality

Revenue growth to accelerate through Q2 and into H2, surpassing FY2026 growth levels

Mixed

YoY growth 13.6% (strong), but QoQ growth 1.7% (modest). H1 FY27 cumulative was 5.4% QoQ. No acceleration; seasonality and Saudi headwind evident.

Margin expansion to continue

Overstated

EBIT margin 15.6% (flat YoY, +10 bps QoQ). PAT margin 11.7% (down vs adjusted Q1 ~11.5%, down vs prior year 11.9%). Expansion not evident.

AI revenue growing 40% YoY, 13.4% of total revenue

Supported

AI revenue = 13.4% × ₹11,808 Cr ≈ ₹1,581 Cr. 40% YoY growth is plausible and supported by strong enterprise AI momentum (47% YoY). Order inflow majority AI-led.

What Changed on This Call

The strategic shift is stark: management is actively pivoting from traditional large-TCV deals (2–3 year engagements) to short-duration AI-centric projects (6–12 month tenures). This reshapes the order book. Order inflow hit USD 1.3 billion, the highest in recent quarters, but management explicitly stated the majority are AI-led, shorter-tenure, faster revenue realization deals. This is intentional—management believes AI project margins are better than traditional services and velocity matters more than contract length. But it trades visibility (traditional large TCV deals are revenue-rich and long-tenured) for execution risk (short-duration projects must convert fast and at scale to sustain growth). Management is deferring ACV (annual contract value) disclosure to investors by 'a couple more quarters' until they have enough historical data to quantify the conversion velocity. That lack of clarity, on a call where growth acceleration was promised, is a yellow flag.

On the wins side, management announced the addition of a USD 100 million+ customer in BFSI (banking, financial services, insurance)—the first such win in several years. This customer was undergoing vendor consolidation (50+ vendors → 5), and LTIMindtree was selected as one of the five strategic partners. This is a credibility vote, but it also illustrates the lumpiness the market should expect: consolidation deals are episodic, and LTM's ability to grow within an account depends on winning new phases of that consolidation.

How the Street Is Positioned

The market's verdict is clear: bearish. The stock trades at ₹4,298 (as of 2026-10-21), down 43.41% from its all-time high of ₹7,595.25. It sits below its 50-day and 200-day moving averages (₹4,352.02 and ₹4,537.51, respectively), though above the 20-day SMA of ₹4,099.38. The RSI of 55.5 is neutral—no extreme oversold condition, but no momentum either.

More telling: both foreign and domestic institutional investors are pulling back. FII holdings have contracted to 6.31% (down 0.32 percentage points QoQ), while DII have trimmed to 16.83% (down 0.18 pp). This is not a buy-the-dip vote; it's an exit vote. FII outflow in a 43% drawdown from ATH suggests institutions have lost conviction in the recovery narrative. They may be waiting for evidence of earnings leverage before returning. The promoter holding of 68.49% has barely budged (down 0.03 pp), so no insider selling panic, but the absence of meaningful promoter buying into a downturn is also notable.

Reconciling the market view with the fundamental story: the 43% drawdown reflects rational skepticism. Management promised acceleration and margin expansion; they delivered top-line growth but earnings stagnation and sequential deceleration. Revenue growth without earnings growth is a marketing story. The 6–12 month AI deal pivot adds lumpiness and execution risk that the market is right to discount. The FII/DII exit is not irrational panic; it's a signal that institutions are waiting for the execution story to firm up before re-entering. The stock's repricing is not yet overdone—there is no extreme RSI or panic volume—but it is justified by unresolved fundamental issues.

Risks, Ranked by Severity

What should concern a holder most

Earnings leverage gap widens

High

PAT flat YoY despite 13.6% revenue growth is unacceptable for a high-growth IT services firm. This signals margin compression, cost inflation, or adverse deal mix (short-duration AI projects may offer volume but not margin). If earnings don't catch up to revenue by H2, the stock reprices lower. This is the central issue holding the market back.

Short-duration AI deal conversion timing and mix risk

High

Management is betting on 6–12 month AI projects to drive growth, but refuses to quantify ACV metrics for 1–2 more quarters. The order book (USD 1.3B) is unproven at conversion velocity and margin. If shorter projects translate to lower win rates or customer churn (vs sticky 2–3 year traditional contracts), revenue growth collapses when TCV inflow slows. Execution risk is real.

Sequential growth deceleration persists into Q3+

Medium-High

Q2 delivered 1.7% QoQ growth (with PAT down 6.0% QoQ), not the acceleration promised. Management attributed this to Tech Services seasonal renewal cycle and Saudi Arabia headwind (~0.7% of revenue). If Q3 doesn't show >6% QoQ growth, the 'H2 > H1' promise fails, and the deceleration narrative becomes entrenched. Sequential momentum is credibility.

Geopolitical and macro headwinds amplify

Medium

Saudi Arabia JV business declined materially; management estimates ~0.7% of total revenue at risk. Travel/hospitality segment (Consumer vertical) hit by energy crisis and fuel price inflation. Both are uncontrollable and unforeseeable. If Middle East tensions escalate or travel remains constrained, Q3+ revenue growth stalls. Limited mitigation available.

Vendor consolidation creates revenue lumpiness

Medium

The ₹100 million+ BFSI customer win shows competitive strength, but consolidation deals are episodic and lumpy. Next phases of consolidation (the 50+ to 5 vendor reduction is multi-year) may see additional rationalization. Pricing power may also erode as vendors compete for the remaining slots. LTM's growth becomes dependent on consolidation cycles, not organic customer expansion.

Cash flow deterioration signals working capital or project timing issues

Medium

OCF-to-PAT 24% (vs 63% Q1) is alarming. Management expects gratuity and TDS normalization by October, but if cash conversion remains below 45–50% into Q3+, it suggests structural working capital drag or deal project timing lumps. Either way, earnings quality is suspect.

The Debate

What to Watch Next

The Next Two Quarters Will Resolve the Debate
  • 1 · H2 Sequential Growth Acceleration

    Management promised 'stronger sequential growth' in H2 vs H1 (which was 5.4% QoQ cumulative). Q3 must show ≥6–7% QoQ revenue growth to credibly signal acceleration and recovery from Saudi/seasonal headwinds. Any miss validates the deceleration narrative and raises questions about demand.

  • 2 · Q3 Cash Flow Normalization

    Gratuity funding and TDS outflows should finish by October. If OCF-to-PAT stays below 45–50% in Q3 (vs historic 60–70%), it signals structural working capital drag, not timing. This would suggest deal project cycles are lumpy or receivables management is deteriorating.

  • 3 · Randstad Digital Acquisition Approvals & Integration Start

    Expected Q3 FY27. If approved, integration risk begins; watch for EBIT margin impact from amortization and synergy realization delays. Management guided to maintained 15.5–15.6% consolidated EBIT, but execution risk is real.

  • 4 · ACV Metrics and Deal Conversion Clarity

    By Q4 FY27 / Q1 FY28, management must quantify how the USD 1.3B order inflow translates to Q4/Q1 revenue and at what margin. The 'wait a couple more quarters' deferral cannot extend indefinitely. Investors need visibility on whether short-duration AI deals are sustainable growth drivers.

  • 5 · Organic PAT Growth (Normalized for One-Timers)

    This is the number to track. Once gratuity/TDS/Q1 Voicing.AI gain effects are normalized out, does Q3 PAT grow in high-single digits? If yes, earnings leverage is recovering. If PAT stalls again, the gap is structural.

LTIMindtree delivered strong revenue growth this quarter—13.6% YoY is respectable—but it came with flat earnings and sequential deceleration. The gap between revenue momentum and earnings stagnation is the real story, and management's vague guidance ('coming close to FY26', deferring ACV clarity) suggests they lack confidence in near-term execution. The market has repriced the stock 43% down from its all-time high, reflecting rational skepticism. FII/DII trimming is not panic; it's a pause.

The next two quarters are critical. If H2 delivers on the 'acceleration' promise and earnings leverage shows up, the AI story wins and the stock reprices higher. If sequential growth stalls and PAT remains flat, the leverage gap becomes structural, and there is room for further repricing lower. For now, the verdict is Hold: a quality company with credible AI momentum, but unproven execution on margin expansion. The number to track from here is organic PAT growth (normalized for gratuity, TDS, and one-time investment gains). If that accelerates in H2, hold for recovery. If it stalls, the market's skepticism will deepen.

Informational and educational content only. Not investment advice.